Production (Stage)
Eton Pharmaceuticals, Inc.
ETON
$14.30
-$0.21-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.58M | -3.82M | -5.48M | -6.69M | 913.00K |
| Total Depreciation and Amortization | 1.91M | 1.13M | 1.10M | 1.01M | 922.00K |
| Total Amortization of Deferred Charges | 1.38M | 1.11M | 100.00K | 101.00K | 113.00K |
| Total Other Non-Cash Items | 4.77M | 3.25M | 3.22M | 3.23M | 3.17M |
| Change in Net Operating Assets | 2.06M | -698.00K | 3.19M | 2.39M | 771.00K |
| Cash from Operations | 5.53M | 969.00K | 2.12M | 42.00K | 5.89M |
| Capital Expenditure | -12.00K | -26.00K | -14.00K | -14.00K | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -30.00M | -30.00M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.12M | -9.99M | -2.64M | -2.64M | -2.64M |
| Cash from Investing | -38.13M | -40.01M | -2.66M | -2.66M | -2.66M |
| Total Debt Issued | 25.31M | 25.31M | -- | -- | -- |
| Total Debt Repaid | -770.00K | -1.16M | -1.54M | -1.54M | -1.54M |
| Issuance of Common Stock | 8.83M | 8.44M | 267.00K | 283.00K | 254.00K |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.37M | 32.59M | -1.27M | -1.26M | -1.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 765.00K | -6.45M | -1.81M | -3.87M | 1.95M |